No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Indatuximab ravtansine in combination with immunomodulatory drugs shows objective and clinical response in patients with relapsed or refractory multiple myeloma

byKathleen Lau

September 23, 2021

in StudyGraphics

#VisualAbstract: Perioperative oxiplatin with S-1 significantly improves survival in patients with advanced gastric cancer or gastroesophageal adenocarcinoma undergoing D2 gastrectomy

RelatedReports

Quick Take: Hospital volume and outcomes for acute pulmonary embolism

Cardiology

Analysis of clinical outcomes utilizing ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism

April 30, 2025

Lessons from real-world implementation of lung cancer screening

Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025

#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation

StudyGraphics

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

April 22, 2025

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Patients with a previous allergy history and women are at increased risk of rare anaphylactic reaction to mRNA COVID-19 vaccines

Quick Take: Association of Prenatal Exposure to Air Pollution with Autism Spectrum Disorder

Early iBASIS–Video Interaction to Promote Positive Parenting therapy reduced autism spectrum disorder symptom severity and diagnosis rate

California Fires: This Is What Happens When You Breathe In Smoke

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports